Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men - A clinical research center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3654-3662

  Wang, C ^a   Eyre, D R ^b   Clark, R ^c   Kleinberg, D ^d   Newman, C ^d   Iranmanesh, A ^e   Veldhuis, J ^f   Dudley, R E ^g   Berman, N ^a   Davidson, T ^a   Barstow, T J ^a   Sinow, R ^a   Alexander, G ^h   Swerdloff, R S ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g Bio Technology General Corporation   (United States)

^h UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; CALCIUM; COLLAGEN TYPE 1; CREATININE; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BONE MINERAL; CALCIUM EXCRETION; CLINICAL FEATURE; CLINICAL TRIAL; DRUG FORMULATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; MUSCLE MASS; MUSCLE STRENGTH; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROSTATITIS; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ADULT; ANTHROPOMETRY; BODY COMPOSITION; BONE REMODELING; BONE RESORPTION; DIHYDROTESTOSTERONE; ESTRADIOL; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; MUSCLES; PROGESTERONE; SEX; TESTOSTERONE;

EID: 10244222400     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3654     Document Type: Article

References (50)

1. Colvard DS, Eriksen EF, Keeting PE, et al. 1989 Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 86:854-857.
2. Kasperk CH, Wegedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ. 1989 Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology. 124:1576-1578.
3. Orwoll ES, Stribrska L, Ramsey EE, Keenan EJ. 1991 Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int. 49:182-187.
4. Carrascosa A, Audi L, Ferrandez MA, Ballabriga A. 1990 Biological effects of androgens and identification of specific dihydrotestosterone-binding sites in cultured human fetal epiphyseal chondrocytes. J Clin Endocrinol Metab. 70:134-140.
5. Kapur SP, Reddi AH. 1989 Influence of testosterone and dihydrotestosterone on bond-matrix induced endochondral bone formation. Calcif Tissue Int. 44:108-113.
6. Pilbeam CC, Raisz LG. 1990 Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae. J Bone Miner Res. 5:1183-1188.
7. Kasperk C, Fitzsimmons R, Strong D, et al. 1990 Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab. 71:1322-1329.
8. Fukayama S, Tashjian HJ. 1989 Direct modulation by androgens of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 125:1789-1794.
9. 1(I)-procollagen and transforming growth factor-B steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology. 127:2723-2730.
10. Corvol MT, Carrascosa A, Tsagris L, Blanchard O, Rappaport R. 1987 Evidence for a direct in vitro action of sex steroids on rabbit cartilage cells during skeletal growth: influence of age and sex. Endocrinology. 120:1422-1429.
11. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley Jr WF. 1987 Osteoporosis in men with idopathic hypogonadotropic hypogonadism. Ann Intern Med. 106:354-361.
12. Arisaka O, Arisakj M. 1991 Effect of testosterone on radial bone mineral density in adolescent male hypogonadism. Acta Paediatr Scand. 80:378-380.
13. Horowitz M, Wishart JM, O'Loughlin PD, Morris HA, Need AG, Nordin BE. 1992 Osteoporosis and Kleinfelter's syndrome. Clin Endocrinol (Oxf). 36:113-118.
14. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A. 1992 Osteopenia in men with a history of delayed puberty. N Engl J Med. 326:600-604.
15. Foresta C, Ruzza G, Mioni R. 1983 Testosterone and bone loss in Klinefelter's syndrome. Horm Metab Res. 15:56-67.
16. Stepan JJ, Lachman M. 1989 Castrated men with bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 69:523-527.
17. Greenspan SL, Neer RM, Ridgway EC, Klibanski A. 1986 Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 104:777-782.
18. Greenspan SL, Oppenheim DS, Klibanski A. 1989 Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med. 110:526-531.
19. Diamond T, Stiel D, Posen S. 1991 Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis. J Bone Miner Res. 6:39-43.
20. Isaia G, Mussetta M, Pecchio F, Sciolla A, Di Stefano M, Molinatti GM. 1992 Effect of testosterone on bone in hypogonadal males. Maturitas. 15:47-51.
21. Devogelaer JP, De Cooman SX, Nagant de Deuxchaisnes C. 1992 Low bone mass in hypogonadal males: effect of testosterone substitution therapy, a densitometric study. Maturitas. 15:17-23.
22. Finkelstein JS, Klibanski A, Neer RM, et al. 1989 Increase in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocnnol Metab. 69:776-783.
23. Wong FHW, Pun KK, Wang C. 1993 Loss of bone mass in patients with Kleinfelter's syndrome despite sufficient testosterone replacement. Osteoporosis Int. 7:281-287.
24. Kubler A, Schulz G, Cordes V, Bayer J, Krause U. 1992 The influence of testosterone substitution on bone mineral density in patients with Kleinfelter's syndrome. Exp Clin Endocrinol. 100:129-132.
25. Griggs RC, Kingston W, Josefowicz RF, Hen BE, Forbes G, Halliday D. 1989 Effect of testosterone on muscle mass and muscle protein synthesis. Am J Appl Physiol. 66:498-503.
26. Welle S, Jozefowicz R, Forbes G, Gringgs RC. 1992 Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy. J Clin Endocrinol Metab. 74:332-335.
27. Young NR, Baker HWG, Liu G, Seeman E. 1993 Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. J Clin Endocrinol Metab. 77:1028-1032.
28. Bhasin S, Storer T, Strakora J, et al. 1994 Testosterone increases lean body mass, muscle size and strength in hypogonadal men [Abstract]. Clin Res. 42:74A.
29. Urban RJ, Bodenburg YH, Gilkison C, et al. 1995 Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 265:E820-E826.
30. Morley JE, Perry HM, Kaiser FE, et al. 1993 Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriat Soc. 41:149-152.
31. Tenover JS. 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 75:1092-1098.
32. Salahian B, Wang C, Alexander G, et al. 1995 Pharmacokinetics, bioefficacy and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate. J Clin Endocrinol Metab. 80:3567-3575.
33. Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR. 1992 A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
34. Koch GG, Landis JR, Freddman JL, Freeman DH, Lehnen TG. 1977 A general methodology for the analysis of experiments with repeated measurement of categorical data. Biometrics. 33:133-158.
35. Marascuilo LA, Mcsweeney M. 1977 Nonparametric and distribution-free methods for the social sciences. Brooks/Cole; 306-307.
36. Gallagher JC, Riggs BL, Eisman J, Manstra A, Arnaud SB, DeLuca HF. 1979 Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest. 64:729-736.
37. Gallagher JC, Riggs BL, DeLuca HF. 1980 Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab. 51:1359-1364.
38. Sokoll LJ, Dawson-Hughes B. 1989 Effect of menopause and aging on serum total and ionized calcium and protein concentrations. Calcif Tissue Int. 44:181-185.
39. McKane WR, Khoola S, Burritt MF, et al. 1995 Mechanism of renal calcium conservation with estrogen replacement therapy in women in early post menopause-a clinical research center study. J Clin Endocrinol Metab. 80:3458-3464.
40. Nordin BEC, Need AG, Morris HA, Horowitz M, Robertson WG. 1991 Evidence for a renal calcium leak in postmenopausal women. J Clin Endocrinol Metab. 72:401-407.
41. Charles P, Hasling C, Risteli L, Mosekilde L, Eriksen EF. 1992 Assessment of bone formation by biochemical markers in metabolic bone disease-separation between osteoblastic activity at the cell and tissue level. Calcif Tissue Int. 51:406-411.
42. Delmas PD. 1993 Biochemical markers of bone turnover. J Bone Miner Res. 8(Suppl 2):S549-S556.
43. Parviainen M, Kuronen I, Kokko H, Lakaniemi M, Savolainen K, Mononen I.1994 Two-site enzyme immunoassay for measuring intact human osteocalcin in serum. J Bone Miner Res. 9:347-354.
44. Hassager C, Jensen LT, Pedenphant, et al. 1990 Collagen synthesis in post-menopausal women during therapy with anabolic steroid or female sex hormones. Metabolism. 39:1167-1169.
45. Raisz LG, Wiita B, Artis A, et al. 1995 Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 81:37-43.
46. Behre HM, Bohmeyer J, Nieschlag E. 1994 Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf). 40:341-349.
47. Bhasin S, Gabelnick HL, Spieler JM, Swerdloff RS, Wang C (eds). 1996 Pharmacology, biology, and clinical applications of androgens. New York: Wiley-Liss.
48. Gooren LJG. 1987 Androgen levels and sex function in testosterone treated hypogonadal men. Arch Sex Behav. 16:463-473.
49. Wang C, Alexander G, Berman N, et al. Testosterone replacement therapy improves mood in hypogonadal men. J Clin Endocrinol Metab. In press.
50. Gregory JW, Greene SA, Thompson J, Scrimgeour CM, Rennie MJ. 1992 Effects of oral testosterone undecanoate on growth, body composition, strength and energy expenditure of adolescent boys. Clin Endocrinol (Oxf). 37:207-213.